Form 4 holding
Interim CFO, Director
NANOMIX Corp
- Security class
- Common Stock
- Shares / value
- 1,695,176
- Estimated value
- $423,794
- Report date
- 30 Nov 2022
- Price
- $0.2500
- Ownership
- Direct
David Ludvigson
Insider Reports History
- Reporting-owner location
- San Francisco, CA
- Latest reporting-owner signature
-
/s/ David Ludvigson
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for David Ludvigson
Form 4 holding
Interim CFO, Director
NANOMIX Corp
- Security class
- Incentive Stock Option (right to buy)
- Shares / value
- 1,695,176
- Estimated value
- Report date
- 30 Nov 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by David Ludvigson
4
NANOMIX Corp
- Report period
- 01 Dec 2022
- Transactions
- 2
- Transaction value
- +$2,447
- Accepted by SEC
- 16 Dec 2022, 16:12
- Role
- Interim CFO, Director
- Next action
- Open filing details
3
Boston Therapeutics, Inc.
- Report period
- 04 Jun 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 29 Jun 2021, 20:46
- Role
- CEO and President, Director
- Next action
- Open filing details